Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The objective of this study is to evaluate the long-term plasma and urine pharmacokinetic parameters of Cardionat®, capsules 250 mg, when used in healthy athlete volunteers. The study consists of four steps: - Step 1. Screening - selecting healthy volunteers for inclusion in the study; - Step 2. Assignment in one of the study group, prescription of the study drug; - Step 3. Samples collections...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 January 2018.

1 Nov 2016 22 Apr 2016 5 Jul 2018 10 Aug 2018 1 Feb 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Basic Science
  • Endpoint: Pharmacokinetics Study
  • Intervention: Parallel Assignment